Article
Review article: targeted screening for hereditary haemochromatosis in high-risk groups.
Alimentary pharmacology & therapeutics - 1 Jul 2004
DuBois S, Kowdley K V
Abstract excerpt
Patients with hereditary haemochromatosis are at risk for significant morbidity from iron overload as well as reduced life-expectancy once cirrhosis is established. Although inexpensive, sensitive screening tests and effective therapy are available, there is continued debate regarding the utility of screening for this condition because of recent data suggesting that the homozygous haemochromatosis mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
